Bank of New York Mellon Corp

Bank

Position in ABOS — Acumen Pharmaceuticals, Inc.

CIK 1390777 NEW YORK, NY

Position in ABOS

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$332,085

+$232,802 QoQ

Shares Held

124,377

+37.8% QoQ

Ownership

0.172%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#28

of 96 holders

Holding Since

Sep 2021

8 quarters on record

Voting authority Sole 87% Shared 0% None 13%

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. ABOS ranks #271 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,672,623	$830,842,010
2	REGN	Regeneron Pharmaceuticals, Inc.	758,492	$472,950,091
3	JAZZ	Jazz Pharmaceuticals plc	1,578,013	$380,253,782
4	ALNY	Alnylam Pharmaceuticals, Inc.	492,071	$148,128,128
5	INSM	INSMED Inc	1,312,756	$139,966,036
6	MRNA	Moderna, Inc.	1,701,675	$119,168,293
7	RVMD	Revolution Medicines, Inc.	601,056	$112,565,759
8	INCY	Incyte Corp	972,825	$110,279,435

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$332,085	124,377	+37.8%	Shares	Defined	2026-08-06
2025-03-31	$99,283	90,258	-2.9%	Shares	Defined	2025-04-29
2024-12-31	$159,930	92,983	0.0%	Shares	Defined	2025-02-04
2024-09-30	$230,596	92,983	-26.5%	Shares	Defined	2024-11-12
2024-06-30	$305,940	126,422	+83.3%	Shares	Defined	2024-07-25
2022-03-31	$269,676	68,971	+259.6%	Shares	Defined	2022-05-11
2021-12-31	$129,655	19,180	+6.9%	Shares	Defined	2022-02-11
2021-09-30	$266,661	17,945	—	Shares	Defined	2021-11-18
No filing history on record for this holder in this stock.